Pept AI (PEPTAI)

Pept AI is a DeSci fleet of autonomous AI agents tailor-built for automated peptide drug discovery. It aims to streamline the process of new drug discovery worldwide by eliminating handoffs between the discovery, synthesis, and wet-lab validation stages.

The system consists of five AI agent-receptors targeting GLP-1R, KISS1R, and OX2R, along with one receptor yet to be chosen by the community, with PeptAI serving as the head of the process. It continuously designs peptides computationally through its AI agent-receptors and submits them for validation across 8 computational gates.

The validation results are then published via the Molecule protocol, making them verifiable on-chain. Subsequently, the validated data is automatically forwarded to wet-lab experiments through Adaptyv Bio, after which PeptAI refines the candidate based on the experimental results.

🪙 PeptAI token: On May 1st, 2026, PeptAI DeSci company announced a public $PEPTAI token sale on Bio launchpad, aiming to raise $50K. However, the project hasn’t disclosed any info on the token utility yet. 
 

Considering this info, the CoinLaunch team conducted a complete review of the Pept AI crypto project and found some of its pros and cons:
 

✅ PeptAI pros:

• Interesting concept and well-designed product;
• Strong AI narrative within the crypto space;
• Robust development ecosystem (Base).

❌ PeptAI cons:

• No available information on revenue or user base;
• Very low scores across SMM, PR, SEO, Growth Marketing, and Influencer Marketing;
• Weak partnerships within Web3;
• Very weak backers;
• Anonymous team.